Office of the Secretary Notice of Meeting, 71967 [2019-28156]
Download as PDF
Federal Register / Vol. 84, No. 249 / Monday, December 30, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary Notice of
Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Task Force on Research
Specific to Pregnant Women and
Lactating Women.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Task Force on
Research Specific to Pregnant Women and
Lactating Women.
Date: February 3, 2020.
Time: 8:30 a.m. to 4:45 p.m.
Agenda: The Task Force is charged with
providing advice and guidance to the
Secretary of HHS, regarding Federal activities
related to identifying and addressing gaps in
knowledge and research regarding safe and
effective therapies for pregnant women and
lactating women, including the development
of such therapies and the collaboration on
and coordination of such activities.
8:00 a.m. Registration
8:30 a.m.–4:45 p.m. Open Session
Place: NICHD Offices, Multipurpose Room
1425/1427 (1st Floor), 6710B Rockledge
Drive, Bethesda, MD 20892.
Contact Person: Lisa Kaeser, Executive
Secretary, Office of Legislation and Public
Policy, Eunice Kennedy Shriver, National
Institute of Child Health and Human
Development, Bethesda, MD 20892, (301)
496–0536, kaeserl@mail.nih.gov.
Public comments are welcome either by
filing written comments in advance and/or
providing oral comments at the meeting.
Written comments to be included at the
meeting should be sent to Lisa Kaeser by 5:00
p.m. on Friday, January 24, 2020. Brief oral
comments from the public may occur during
the discussion periods following each of the
four working group presentations.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto NIH federal property. Visitors will be
asked to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit.
Details and additional information about
this meeting, prior meetings, and the Task
Force’s 2018 Report and Recommendations
can be found at the NICHD website for the
Task Force on Research Specific to Pregnant
Women and Lactating Women (PRGLAC):
https://www.nichd.nih.gov/about/advisory/
PRGLAC/Pages/index.aspx Presentations
VerDate Sep<11>2014
20:00 Dec 27, 2019
Jkt 250001
made during the meeting and any written
comments will be formatted to be posted on
the PRGLAC website for the record.
Registration Link: https://tiny.cc/
PRGLAC0220.
Please note: This meeting will be available
through NIH Videocast. If you are planning
on watching the videocast remotely, please
select this option on the registration form.
Dated: December 23, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–28156 Filed 12–27–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request PHS Applications
and Pre-Award Reporting
Requirements (OD/OPERA)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Mikia P.
Currie, Project Clearance Branch, Office
of Policy for Extramural Research
Administration, NIH, Rockledge 1
Building, Room 803–C, 6705 Rockledge
Drive, Bethesda, MD 20892–7974, or
call non-toll-free number (301) 435–
0941, or email your request, including
your address to:
projectclearancebranch@mail.nih.gov.
ADDRESSES:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
71967
This
proposed information collection was
previously published in the Federal
Register on April 12, 2019, Volume 84,
No.212 pages 14956–14957 and allowed
60 days for public comment. One public
comment was received. The purpose of
this notice is to allow an additional 30
days for public comment. The Office of
the Director, NIH, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
SUPPLEMENTARY INFORMATION:
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the NIH has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
Proposed Collection: Public Health
Service (PHS) Applications and Preaward Reporting Requirements.
Revision, OMB 0925–0001, Expiration
Date 3/31/2020. Form numbers: PHS
398, PHS416–1, 416–5, and PHS 6031.
This collection represents a
consolidation of PHS applications and
pre-award reporting requirements into a
revised data collection under the PRA.
This collection includes the proposed
use of a new PHS Human Subjects and
Clinical Trial Information form.
Need and Use of Information
Collection: NIH has received approval to
require applicants and recipients to
address Human Fetal Tissue
requirements within the SF–424 R&R
and the Research Performance Progress
Report due to Congressional ((Sections
498A and 498B of the PHS Act (42
U.S.C. 289g–1 and 289g–2)) and
Department of Health and Human
Services (45 CFR 46.204 and 46.206)
mandates regarding human fetal tissue
research. Applicants and recipients will
be required to comply with Federal and
state laws concerning the acquisition of
human fetal tissue (including cell lines)
obtained from elective abortions as well
as include a description of the proposed
characteristics of the human fetal cells/
tissue outlining the procurement budget
details, and how the applicants/
recipients will document the processes
for how they will use the human fetal
tissues and cells. Additionally, this
revision will clarify information
regarding an institutional commitment
to ensuring that proper policies,
procedures, and oversight are in place to
E:\FR\FM\30DEN1.SGM
30DEN1
Agencies
[Federal Register Volume 84, Number 249 (Monday, December 30, 2019)]
[Notices]
[Page 71967]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28156]
[[Page 71967]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Task Force on
Research Specific to Pregnant Women and Lactating Women.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Task Force on Research Specific to Pregnant
Women and Lactating Women.
Date: February 3, 2020.
Time: 8:30 a.m. to 4:45 p.m.
Agenda: The Task Force is charged with providing advice and
guidance to the Secretary of HHS, regarding Federal activities
related to identifying and addressing gaps in knowledge and research
regarding safe and effective therapies for pregnant women and
lactating women, including the development of such therapies and the
collaboration on and coordination of such activities.
8:00 a.m. Registration
8:30 a.m.-4:45 p.m. Open Session
Place: NICHD Offices, Multipurpose Room 1425/1427 (1st Floor),
6710B Rockledge Drive, Bethesda, MD 20892.
Contact Person: Lisa Kaeser, Executive Secretary, Office of
Legislation and Public Policy, Eunice Kennedy Shriver, National
Institute of Child Health and Human Development, Bethesda, MD 20892,
(301) 496-0536, [email protected].
Public comments are welcome either by filing written comments in
advance and/or providing oral comments at the meeting. Written
comments to be included at the meeting should be sent to Lisa Kaeser
by 5:00 p.m. on Friday, January 24, 2020. Brief oral comments from
the public may occur during the discussion periods following each of
the four working group presentations.
In the interest of security, NIH has instituted stringent
procedures for entrance onto NIH federal property. Visitors will be
asked to show one form of identification (for example, a government-
issued photo ID, driver's license, or passport) and to state the
purpose of their visit.
Details and additional information about this meeting, prior
meetings, and the Task Force's 2018 Report and Recommendations can
be found at the NICHD website for the Task Force on Research
Specific to Pregnant Women and Lactating Women (PRGLAC): https://www.nichd.nih.gov/about/advisory/PRGLAC/Pages/index.aspx
Presentations made during the meeting and any written comments will
be formatted to be posted on the PRGLAC website for the record.
Registration Link: https://tiny.cc/PRGLAC0220.
Please note: This meeting will be available through NIH
Videocast. If you are planning on watching the videocast remotely,
please select this option on the registration form.
Dated: December 23, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-28156 Filed 12-27-19; 8:45 am]
BILLING CODE 4140-01-P